Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL
Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1, and the funding-status notice has been removed.SummaryDifference0.5%

- Check22 days agoChange DetectedAdded a site-wide notice about a lapse in government funding, indicating information may not be up to date and transactions may not be processed until appropriations are enacted, with guidance to check status on cc.nih.gov and opm.gov. Updated the page revision tag to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check30 days agoChange DetectedAdded UI/metadata items Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check65 days agoChange DetectedFooter updated to display Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision: v3.3.2 is displayed, replacing v3.3.1. No substantive study information appears to have changed.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed, a metadata update with no change to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL
Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.